Cleared Traditional

K232152 - NerivioInfinity (FDA 510(k) Clearance)

Nov 2023
Decision
112d
Days
Class 2
Risk

K232152 is an FDA 510(k) clearance for the NerivioInfinity. This device is classified as a Distal Transcutaneous Electrical Stimulator For Treatment Of Acute Migraine (Class II - Special Controls, product code QGT).

Submitted by Theranica Bioelectronics , Ltd. (Netanya, IL). The FDA issued a Cleared decision on November 8, 2023, 112 days after receiving the submission on July 19, 2023.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.5899. A Trunk And Limb Electrical Stimulator To Treat Headache Is A Device Intended To Treat Headache Through The Application Of Electrical Stimulation Anywhere On The Body Of The Patient Apart From The Patient's Head Or Neck Through Electrodes Placed On The Skin. The Stimulation May Be Provided Transcutaneously Or Percutaneously..

Submission Details

510(k) Number K232152 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 19, 2023
Decision Date November 08, 2023
Days to Decision 112 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code QGT - Distal Transcutaneous Electrical Stimulator For Treatment Of Acute Migraine
Device Class Class II - Special Controls
CFR Regulation 21 CFR 882.5899
Definition A Trunk And Limb Electrical Stimulator To Treat Headache Is A Device Intended To Treat Headache Through The Application Of Electrical Stimulation Anywhere On The Body Of The Patient Apart From The Patient's Head Or Neck Through Electrodes Placed On The Skin. The Stimulation May Be Provided Transcutaneously Or Percutaneously.